49 results on '"Elling D"'
Search Results
2. Efficacy and Patient Satisfaction of Breast Conserving Therapy for Central Breast Cancer by the B Technique
3. Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial
4. Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study
5. Poly(phenylenesulfide)-based coatings for carbon steel heat exchanger tubes in geothermal environments
6. Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial
7. Quality of care of VLBW-neonates: relationship between unit volume and outcome is different between metropolitan and rural regions
8. Quality of care of VLBW neonates: relationship between unit volume and outcome is different between metropolitan and rural regions
9. Gemcitabine, myocet and docetaxel for primary treatment of breast cancer: V269
10. A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy
11. Neoadjuvante Chemotherapie mit Gemcitabin als verlängerte Infusion, liposomalem Doxorubicin und Docetaxel: Ergebnisse einer Phase-I-Studie: V5–4
12. Adjuvant treatment of breast cancer patients with 1–3 positive lymph nodes: vinorelbine plus epirubicin; vinorelbine plus epirubicin sequential followed up by paclitaxel; epirubicin plus cyclophosphamide; epirubicin plus cyclophosphamide sequential followed up by paclitaxel. A phase II study
13. Vinorelbine plus epirubicin (VE) and vinorelbine plus epirubicin sequential followed by paclitaxel (VE/T) as adjuvant chemotherapy in breast cancer patients with 1-3 positive lymph nodes: Phase II study.
14. Intraductal component in invasive breast cancer: analysis of 250 resected surgical specimens
15. 257O - Intense Dose-Dense Epirubicin (E), Paclitaxel (T), Cyclophosphamide (C) (Iddetc) is Highly Effective in Adjuvant Therapy of Node-Positive Breast Cancer Patients (Pts). an Analysis of the Gbg, Ago-B, and Noggo Study Groups
16. Comparative Study of Surgical Margins and Cosmetic Outcome in Lumpectomy versus Segmental Resection in Breast Cancer.
17. Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study.
18. Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO.
19. Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer.
20. P199 The 70-gene Mammaprint signature is an independent prognostic factor for elderly women with hormone receptor-positive, HER2-negative breast cancer
21. Malignant melanoma metastatic to the breast: an interdisciplinary challenge.
22. New approach to tumor marking. Clip implantation prior to primary chemotherapy on patients with mammary carcinoma
23. Dose-intensive adjuvant chemotherapy with epirubicin/paclitaxel vs. epirubicin/cyclophosphamide in breast cancer patients with 4–9/over 9 (second group) positive nodes: preliminary data of this phase II/III trial
24. 376 Primary chemotherapy with gemcitabine (G), myocet (M) and docetaxel (T): results of a phase I/II trial.
25. Development of polymer concrete vaults for natural gas regulator stations
26. Electrically conductive polymer concrete overlay installed in Pulaski, Virginia
27. Phase I/II Trial of primary chemotherapy with non-pegylated liposomal doxorubicin, paclitaxel and lapatinib in patients with HER2-positive, early stage breast cancer.
28. Development of polymer concrete for dike insulation at LNG (liquid natural gas) facilities. Phase 2. Final report, June 1, 1985-August 31, 1986
29. Development of polymer concrete for dike insulation at LNG (liquified natural gas) facilities: Phase 3, Final report, November 1, 1986-August 31, 1987
30. Sex differences and risk factors for diabetes mellitus - an international study from 193 countries.
31. German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
32. Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer.
33. The 70-Gene Signature as Prognostic Factor for Elderly Women with Hormone Receptor-Positive, HER2-Negative Breast Cancer.
34. Influence of a dose-dense adjuvant chemotherapy on sVCAM-1/sICAM-1 serum levels in breast cancer patients with 1-3 positive lymph nodes.
35. Transvaginal video-assisted cholecystectomy in clinical practice.
36. Lapatinib in the Treatment of Hormone Receptor-Positive/ErbB2-Positive Breast Cancer.
37. Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.
38. Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes.
39. Dose-dense adjuvant chemotherapy for node-positive breast cancer in women 60 years and older: feasibility and tolerability in a subset of patients in a randomized trial.
40. Chemotherapy treatment options for elderly women with breast cancer.
41. Changes in the circulating plasma levels of VEGF and VEGF-D after adjuvant chemotherapy in patients with breast cancer and 1 to 3 positive lymph nodes.
42. Primary chemotherapy with gemcitabine, liposomal doxorubicin and docetaxel in patients with locally advanced breast cancer: results of a phase I trial.
43. Primary systemic chemotherapy with sequential, dose-dense epirubicin and docetaxel for inoperable, locally advanced inflammatory breast cancer: a phase II study.
44. Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.
45. Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study.
46. First-line chemotherapy with weekly paclitaxel and carboplatin for advanced ovarian cancer: a phase I study.
47. Detection of BRCA1 and BRCA2 mutations in breast cancer families by a comprehensive two-stage screening procedure.
48. Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission.
49. Some aspects of psychiatric nursing.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.